Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Macroeconomic Fluctuations in Home Countries and Immigrants’ Well-Being: New Evidence from Down Under

Our findings suggest that immigrants in Australia have emotional or altruistic connections to their home countries

Research

Modelling factors for Aboriginal and Torres Strait Islander child neurodevelopment outcomes: A latent class analysis

This study highlights a range of unique profiles that can be used for improving the early development of young Aboriginal children

Research

Reading and numeracy attainment of children reported to child protection services: A population record linkage study controlling for other adversities

A cross-agency response to supporting educational attainment for all children reported to child protection services is required

Research

The Deep Genome Project.

The Deep Genome Project—to deliver the functional biological annotation of all human orthologous genomic elements in mice

Research

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia

Cancer cells display DNA hypermethylation at specific CpG islands in comparison to their normal healthy counterparts, but the mechanism that drives this so-called CpG island methylator phenotype (CIMP) remains poorly understood. Here, we show that CpG island methylation in human T-cell acute lymphoblastic leukemia (T-ALL) mainly occurs at promoters of Polycomb Repressor Complex 2 (PRC2) target genes that are not expressed in normal or malignant T-cells and which display a reciprocal association with H3K27me3 binding.

Research

Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data

No new safety concerns were identified for live attenuated herpes zoster vaccine in this study based on a novel, Australian primary care data source

Research

Retrospective Case-Control Study of 2017 G2P[4] Rotavirus Epidemic in Rural and Remote Australia

A widespread G2P[4] rotavirus epidemic in rural and remote Australia provided an opportunity to evaluate the performance of Rotarix and RotaTeq rotavirus vaccines, ten years after their incorporation into Australia's National Immunisation Program.